Cost-effectiveness Analysis of Cervical Cancer Screening Strategies Based on the Papanicolaou Smear Test in Korea

Ko, Min Jung; Kim, Jimin; Kim, Younhee; Lee, Yoon Jae; Hong, Sung Ran; Lee, Jae Kwan

추천

검색

자료유형: 학술저널

저자정보: Ko, Min Jung (Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency) Kim, Jimin (Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency) Kim, Younhee (Institute of Health and Environment and School of Public Health, Seoul National University) Lee, Yoon Jae (Department of Oriental Gynecology, CHA Bundang Medical Center, CHA University) Hong, Sung Ran (Department of Pathology, Cheil General Hospital & Women's Healthcare Center, Catholic Kwandong University) Lee, Jae Kwan (Department of Gynecology, Korea University Guro Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제16권 제6호

발행연도: 2015.1

수록면: 2,317 - 2,322 (6page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Background: Despite the increasing number of screening examinations performed for cervical cancer utilizing the Papanicolaou smear test (Pap test), few studies have examined whether this strategy is cost-effective in Korea. Objective: This study was conducted to evaluate the cost-effectiveness of cervical cancer screening strategies incorporating the Pap test based on age at the start and end of screening as well as screening interval. Materials and Methods: We designed four alternative screening strategies based on patient age when screening was started (20 or 30 years) and discontinued (lifetime, 79 years). Each strategy was assessed at screening intervals of 1, 2, 3, or 5 years. A Markov model was developed to determine the cost-effectiveness of the 16 possible cervical cancer screening strategies, and this was evaluated from a societal perspective. The main outcome measures were average lifetime cost, incremental quality-adjusted life-years (QALYs), and incremental cost-effectiveness ratio (ICER). Results: Compared with various strategies comprising younger starting age, discontinuation age, and longer screening intervals, strategies employing annual screening for cervical cancer starting at a target age of 30 years and above were the most cost-effective, with an ICER of 21,012.98 dollars per QALY gained (with a Korean threshold of 30,000,000 KRW or US$27,272). Conclusions: We found that annual screening for cervical cancer beginning at a target age of 30 years and above is most cost-effective screening strategy. Considering the potential economic advantages, more intense screening policies for cervical cancer might be favorable among countries with high rates of cervical cancer and relatively low screening costs.

#Cervical cancer #cancer screening #Pap smear test #HPV infection #economic evaluation

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

Ko, Min Jung

소속기관 Division for Healthcare Technology Assessment Research, National Evidence-based Healthcare Collabora